New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates - Nrf2 activators and GSK-3 inhibitors Journal Articles Refereed uri icon

Overview

Published in

  • Inflammopharmacology: experimental and clinical studies

Time

Date/time value

  • 2012

Identity

Digital Object Identifier (DOI)

  • 10.1007/s10787-011-0111-7

Additional Document Info

Parent Title

  • Inflammopharmacology: experimental and clinical studies

Volume

  • 20

Publisher

  • Birkhaeuser Verlag AG